Cargando…

Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain

Parkinson's disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB) are neurodegenerative disorders with alpha‐synuclein (α‐syn) aggregation pathology. Different strains of α‐syn with unique properties are suggested to cause distinct clinical and pathological manifestat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuyu, Dauer, Karina, Strohäker, Timo, Tatenhorst, Lars, Caldi Gomes, Lucas, Mayer, Simon, Jung, Byung Chul, Kim, Woojin S., Lee, Seung‐Jae, Becker, Stefan, Liesche‐Starnecker, Friederike, Zweckstetter, Markus, Lingor, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467043/
https://www.ncbi.nlm.nih.gov/pubmed/37485772
http://dx.doi.org/10.1111/bpa.13196
_version_ 1785099026524274688
author Zhang, Shuyu
Dauer, Karina
Strohäker, Timo
Tatenhorst, Lars
Caldi Gomes, Lucas
Mayer, Simon
Jung, Byung Chul
Kim, Woojin S.
Lee, Seung‐Jae
Becker, Stefan
Liesche‐Starnecker, Friederike
Zweckstetter, Markus
Lingor, Paul
author_facet Zhang, Shuyu
Dauer, Karina
Strohäker, Timo
Tatenhorst, Lars
Caldi Gomes, Lucas
Mayer, Simon
Jung, Byung Chul
Kim, Woojin S.
Lee, Seung‐Jae
Becker, Stefan
Liesche‐Starnecker, Friederike
Zweckstetter, Markus
Lingor, Paul
author_sort Zhang, Shuyu
collection PubMed
description Parkinson's disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB) are neurodegenerative disorders with alpha‐synuclein (α‐syn) aggregation pathology. Different strains of α‐syn with unique properties are suggested to cause distinct clinical and pathological manifestations resulting in PD, MSA, or DLB. To study individual α‐syn spreading patterns, we injected α‐syn fibrils amplified from brain homogenates of two MSA patients and two PD patients into the brains of C57BI6/J mice. Antibody staining against pS129‐α‐syn showed that α‐syn fibrils amplified from the brain homogenates of the four different patients caused different levels of α‐syn spreading. The strongest α‐syn pathology was triggered by α‐syn fibrils of one of the two MSA patients, followed by comparable pS129‐α‐syn induction by the second MSA and one PD patient material. Histological analysis using an antibody against Iba1 further showed that the formation of pS129‐α‐syn is associated with increased microglia activation. In contrast, no differences in dopaminergic neuron numbers or co‐localization of α‐syn in oligodendrocytes were observed between the different groups. Our data support the spreading of α‐syn pathology in MSA, while at the same time pointing to spreading heterogeneity between different patients potentially driven by individual patient immanent factors.
format Online
Article
Text
id pubmed-10467043
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104670432023-08-31 Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain Zhang, Shuyu Dauer, Karina Strohäker, Timo Tatenhorst, Lars Caldi Gomes, Lucas Mayer, Simon Jung, Byung Chul Kim, Woojin S. Lee, Seung‐Jae Becker, Stefan Liesche‐Starnecker, Friederike Zweckstetter, Markus Lingor, Paul Brain Pathol Research Articles Parkinson's disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB) are neurodegenerative disorders with alpha‐synuclein (α‐syn) aggregation pathology. Different strains of α‐syn with unique properties are suggested to cause distinct clinical and pathological manifestations resulting in PD, MSA, or DLB. To study individual α‐syn spreading patterns, we injected α‐syn fibrils amplified from brain homogenates of two MSA patients and two PD patients into the brains of C57BI6/J mice. Antibody staining against pS129‐α‐syn showed that α‐syn fibrils amplified from the brain homogenates of the four different patients caused different levels of α‐syn spreading. The strongest α‐syn pathology was triggered by α‐syn fibrils of one of the two MSA patients, followed by comparable pS129‐α‐syn induction by the second MSA and one PD patient material. Histological analysis using an antibody against Iba1 further showed that the formation of pS129‐α‐syn is associated with increased microglia activation. In contrast, no differences in dopaminergic neuron numbers or co‐localization of α‐syn in oligodendrocytes were observed between the different groups. Our data support the spreading of α‐syn pathology in MSA, while at the same time pointing to spreading heterogeneity between different patients potentially driven by individual patient immanent factors. John Wiley and Sons Inc. 2023-07-24 /pmc/articles/PMC10467043/ /pubmed/37485772 http://dx.doi.org/10.1111/bpa.13196 Text en © 2023 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Zhang, Shuyu
Dauer, Karina
Strohäker, Timo
Tatenhorst, Lars
Caldi Gomes, Lucas
Mayer, Simon
Jung, Byung Chul
Kim, Woojin S.
Lee, Seung‐Jae
Becker, Stefan
Liesche‐Starnecker, Friederike
Zweckstetter, Markus
Lingor, Paul
Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
title Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
title_full Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
title_fullStr Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
title_full_unstemmed Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
title_short Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
title_sort alpha‐synuclein fibrils amplified from multiple system atrophy and parkinson's disease patient brain spread after intracerebral injection into mouse brain
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467043/
https://www.ncbi.nlm.nih.gov/pubmed/37485772
http://dx.doi.org/10.1111/bpa.13196
work_keys_str_mv AT zhangshuyu alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain
AT dauerkarina alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain
AT strohakertimo alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain
AT tatenhorstlars alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain
AT caldigomeslucas alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain
AT mayersimon alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain
AT jungbyungchul alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain
AT kimwoojins alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain
AT leeseungjae alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain
AT beckerstefan alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain
AT lieschestarneckerfriederike alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain
AT zweckstettermarkus alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain
AT lingorpaul alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain